Vida Ventures, LLC has bought stock on 3 days since Apr 2018

Vida Ventures, LLC is a next-generation life sciences investment firm and corporate insider that holds a significant ownership stake of approximately 10% in Kyverna Therapeutics, Inc. (KYTX).( Founded in 2017 by a group of scientists, physicians, entrepreneurs, and investors, Vida focuses on building and funding biomedical companies that develop transformative therapies, particularly in oncology and other areas of high unmet medical need.( The firm has a bicoastal presence with offices in Los Angeles, Boston, New York, and Fort Worth, and manages roughly $1.7–1.8 billion in assets under management.(

Vida’s business operations center on early-stage venture and growth investments in biomedical and life sciences companies, where it partners closely with entrepreneurs to translate cutting-edge science into clinical therapies.( The firm is led by an experienced team that includes Founder and Senior Managing Director Arie Belldegrun, M.D., a noted biotech entrepreneur and founder of Kite Pharma; Senior Managing Director Helen S. Kim, M.B.A.; and other managing directors and principals such as Arjun Goyal, M.D., M.B.A., Brian Goodman, Ph.D., and Alex Loftis.( Vida Ventures’ portfolio spans multiple therapeutic areas and platforms, reflecting its mission to “bring science to life” and make a meaningful difference for patients through strategic investment and company formation in the biopharmaceutical sector.(

Written by Perplexity from public sources.